Jennifer Y Xie Selected Research

Jennifer Y Xie Research Topics

Disease

11	Pain (Aches) 01/2019 - 01/2005
9	Neuralgia (Stump Neuralgia) 10/2020 - 03/2009
9	Hyperalgesia 01/2019 - 01/2005
7	Hypersensitivity (Allergy) 01/2019 - 01/2005
4	Migraine Disorders (Migraine) 01/2019 - 11/2014
3	Chronic Pain 10/2020 - 01/2005
2	Neoplasms (Cancer) 01/2023 - 10/2015
2	Pancreatitis 01/2019 - 06/2006
2	Postoperative Pain 02/2014 - 12/2012
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Peripheral Nerve Injuries 10/2020
1	Colitis 01/2019
1	Mood Disorders (Mood Disorder) 01/2019
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Visceral Pain 01/2019
1	Neurofibromatoses (Neurofibromatosis) 12/2017
1	Cancer Pain 10/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
4	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 12/2012
3	Ion Channels (Ion Channel)IBA 10/2020 - 04/2011
3	salicylhydroxamic acid (SHAM)IBA 01/2019 - 03/2014
3	Lacosamide FDA Link 12/2017 - 01/2016
3	Semaphorin-3AIBA 12/2017 - 01/2016
3	Morphine (MS Contin)FDA LinkGeneric 10/2015 - 01/2005
3	Opioid Analgesics (Opioids)IBA 03/2014 - 01/2005
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 10/2015
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2019 - 08/2014
2	Calcium Channels (Calcium Channel)IBA 01/2016 - 04/2011
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2015 - 08/2014
2	Cholecystokinin (Pancreozymin)IBA 03/2009 - 01/2005
2	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 03/2009 - 01/2005
2	dermorphin-saporinIBA 03/2009 - 06/2006
2	Cholecystokinin B ReceptorIBA 03/2009 - 01/2005
2	Lidocaine (Xylocaine)FDA LinkGeneric 06/2006 - 01/2005
1	Cyclic AMP (AMP, Cyclic)IBA 01/2023
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2023
1	erythromycin propionate-N-acetylcysteinateIBA 01/2023
1	CAP1-6DIBA 01/2023
1	BradykininIBA 10/2020
1	dibutyldichlorotinIBA 01/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2019
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2019
1	Neurofibromin 1 (Neurofibromin)IBA 12/2017
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 07/2017
1	norbinaltorphimineIBA 07/2017
1	Sumatriptan (Imigran)FDA LinkGeneric 07/2017
1	Mitogen-Activated Protein KinasesIBA 07/2017
1	U 0126 (UO 126)IBA 07/2017
1	Peptides (Polypeptides)IBA 01/2016
1	Diclofenac (SR 38)FDA LinkGeneric 10/2015
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	KetorolacIBA 08/2014
1	Naproxen (Naprosyn)FDA LinkGeneric 08/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2014
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 03/2014
1	Tapentadol FDA Link 03/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2014
1	A-Form DNA (A-DNA)IBA 02/2014
1	Early Growth Response Protein 1IBA 02/2014
1	Transcription Factors (Transcription Factor)IBA 02/2014
1	Local AnestheticsIBA 12/2012
1	SodiumIBA 04/2011
1	Z 123212IBA 04/2011
1	SaporinsIBA 03/2009
1	Cytotoxins (Cytolysins)IBA 03/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 03/2009
1	Dynorphins (Dynorphin)IBA 06/2006
1	Opiate AlkaloidsIBA 01/2005
1	Analgesics (Analgesic Drugs)IBA 01/2005

Therapy/Procedure

7	Therapeutics 01/2023 - 04/2011
4	Ligation 10/2020 - 04/2011
2	Oral Administration 06/2016 - 04/2011
1	Intravenous Administration 01/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Injections 01/2019
1	Subcutaneous Infusions 01/2016
1	Spinal Injections 02/2014